Wordt geladen...
Antiplatelet Therapy in the Management of Cardiovascular Disease in Patients with CKD: What Is the Evidence?
Antiplatelet agents (APAs) are proven to reduce risk of major cardiovascular events in patients with cardiovascular disease and normal kidney function. With recent post hoc analyses of large trials questioning the safety and efficacy of APAs in CKD, major gaps exist in our understanding of platelet...
Bewaard in:
| Gepubliceerd in: | Clin J Am Soc Nephrol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5972379/ https://ncbi.nlm.nih.gov/pubmed/23024160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06790712 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|